 | • レポートコード：QYR9ST03961 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腫瘍溶解性ウイルス免疫療法の世界市場について調査・分析し、腫瘍溶解性ウイルス免疫療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（工学的腫瘍溶解性ウイルス、野生型腫瘍溶解性ウイルス）、用途別（病院、診療所、外来手術センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍溶解性ウイルス免疫療法市場動向 ・主要企業別マーケットシェア ・腫瘍溶解性ウイルス免疫療法の種類別市場規模2014-2019 （工学的腫瘍溶解性ウイルス、野生型腫瘍溶解性ウイルス） ・腫瘍溶解性ウイルス免疫療法の用途別市場規模2014-2019 （病院、診療所、外来手術センター） ・腫瘍溶解性ウイルス免疫療法の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法の中国市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法の日本国内市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法のインド市場：主要企業・種類別/用途別市場規模 ・腫瘍溶解性ウイルス免疫療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Amgen、TILT Biotherapeutics、Oncorus、Sorrento Therapeutics、Shanghai Sunway Biotech） ・腫瘍溶解性ウイルス免疫療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Oncology Immunotherapy exploits virus’s ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
In 2018, the global Oncolytic Virus Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncolytic Virus Immunotherapy development in United States, Europe and China.
The key players covered in this study
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
…
Market segment by Type, the product can be split into
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players.
To present the Oncolytic Virus Immunotherapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncolytic Virus Immunotherapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Engineering Oncolytic Viruses
1.4.3 Wild-Type Oncolytic Viruses
1.5 Market by Application
1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oncolytic Virus Immunotherapy Market Size
2.2 Oncolytic Virus Immunotherapy Growth Trends by Regions
2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions (2014-2025)
2.2.2 Oncolytic Virus Immunotherapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oncolytic Virus Immunotherapy Market Size by Manufacturers
3.1.1 Global Oncolytic Virus Immunotherapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.3 Key Players Oncolytic Virus Immunotherapy Product/Solution/Service
3.4 Date of Enter into Oncolytic Virus Immunotherapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oncolytic Virus Immunotherapy Market Size by Type (2014-2019)
4.2 Global Oncolytic Virus Immunotherapy Market Size by Application (2014-2019)
5 United States
5.1 United States Oncolytic Virus Immunotherapy Market Size (2014-2019)
5.2 Oncolytic Virus Immunotherapy Key Players in United States
5.3 United States Oncolytic Virus Immunotherapy Market Size by Type
5.4 United States Oncolytic Virus Immunotherapy Market Size by Application
6 Europe
6.1 Europe Oncolytic Virus Immunotherapy Market Size (2014-2019)
6.2 Oncolytic Virus Immunotherapy Key Players in Europe
6.3 Europe Oncolytic Virus Immunotherapy Market Size by Type
6.4 Europe Oncolytic Virus Immunotherapy Market Size by Application
7 China
7.1 China Oncolytic Virus Immunotherapy Market Size (2014-2019)
7.2 Oncolytic Virus Immunotherapy Key Players in China
7.3 China Oncolytic Virus Immunotherapy Market Size by Type
7.4 China Oncolytic Virus Immunotherapy Market Size by Application
8 Japan
8.1 Japan Oncolytic Virus Immunotherapy Market Size (2014-2019)
8.2 Oncolytic Virus Immunotherapy Key Players in Japan
8.3 Japan Oncolytic Virus Immunotherapy Market Size by Type
8.4 Japan Oncolytic Virus Immunotherapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2014-2019)
9.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia
9.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type
9.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application
10 India
10.1 India Oncolytic Virus Immunotherapy Market Size (2014-2019)
10.2 Oncolytic Virus Immunotherapy Key Players in India
10.3 India Oncolytic Virus Immunotherapy Market Size by Type
10.4 India Oncolytic Virus Immunotherapy Market Size by Application
11 Central & South America
11.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2014-2019)
11.2 Oncolytic Virus Immunotherapy Key Players in Central & South America
11.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type
11.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncolytic Virus Immunotherapy Introduction
12.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncolytic Virus Immunotherapy Introduction
12.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 TILT Biotherapeutics
12.3.1 TILT Biotherapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncolytic Virus Immunotherapy Introduction
12.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.3.5 TILT Biotherapeutics Recent Development
12.4 Oncorus
12.4.1 Oncorus Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncolytic Virus Immunotherapy Introduction
12.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.4.5 Oncorus Recent Development
12.5 Sorrento Therapeutics
12.5.1 Sorrento Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncolytic Virus Immunotherapy Introduction
12.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.5.5 Sorrento Therapeutics Recent Development
12.6 Shanghai Sunway Biotech
12.6.1 Shanghai Sunway Biotech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncolytic Virus Immunotherapy Introduction
12.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
12.6.5 Shanghai Sunway Biotech Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Oncolytic Virus Immunotherapy Key Market Segments
Table Key Players Oncolytic Virus Immunotherapy Covered
Table Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Type 2014-2025
Figure Engineering Oncolytic Viruses Figures
Table Key Players of Engineering Oncolytic Viruses
Figure Wild-Type Oncolytic Viruses Figures
Table Key Players of Wild-Type Oncolytic Viruses
Table Global Oncolytic Virus Immunotherapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Oncolytic Virus Immunotherapy Report Years Considered
Table Global Oncolytic Virus Immunotherapy Market Size 2014-2025 (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size by Regions 2014-2025 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size by Regions 2014-2019 (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Share by Regions 2014-2019
Figure Global Oncolytic Virus Immunotherapy Market Share by Regions 2014-2019
Figure Global Oncolytic Virus Immunotherapy Market Share by Regions 2019
Table Market Top Trends
Table Global Oncolytic Virus Immunotherapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Share by Manufacturers (2014-2019)
Figure Global Oncolytic Virus Immunotherapy Market Share by Manufacturers in 2018
Table Global Oncolytic Virus Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncolytic Virus Immunotherapy Product/Solution/Service
Table Date of Enter into Oncolytic Virus Immunotherapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size Share by Type (2014-2019)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Type (2014-2019)
Table Global Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Global Oncolytic Virus Immunotherapy Market Size Share by Application (2014-2019)
Figure Global Oncolytic Virus Immunotherapy Market Size Market Share by Application (2014-2019)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Application in 2018
Figure United States Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table United States Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table United States Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table United States Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table United States Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table United States Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table United States Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure Europe Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table Europe Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Europe Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table Europe Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Europe Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure China Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table China Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table China Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table China Oncolytic Virus Immunotherapy Market Size by Type (2014-20189) (Million US$)
Table China Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table China Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table China Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure Japan Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table Japan Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Japan Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table Japan Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Japan Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure India Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table India Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table India Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table India Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table India Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table India Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table India Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Figure Central & South America Oncolytic Virus Immunotherapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oncolytic Virus Immunotherapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oncolytic Virus Immunotherapy Market Share (2018-2019)
Table Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Oncolytic Virus Immunotherapy Market Share by Type (2014-2019)
Table Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Oncolytic Virus Immunotherapy Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Oncolytic Virus Immunotherapy Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table Merck Recent Development
Table Amgen Company Details
Table Amgen Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table Amgen Recent Development
Table TILT Biotherapeutics Company Details
Table TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)(Million US$)
Figure TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table TILT Biotherapeutics Recent Development
Table Oncorus Company Details
Table Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)(Million US$)
Figure Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table Oncorus Recent Development
Table Sorrento Therapeutics Company Details
Table Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)(Million US$)
Figure Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table Sorrento Therapeutics Recent Development
Table Shanghai Sunway Biotech Company Details
Table Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)(Million US$)
Figure Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2014-2019)
Table Shanghai Sunway Biotech Recent Development
Table Global Oncolytic Virus Immunotherapy Market Size by Regions (Million US$) 2019-2025
Figure Global Oncolytic Virus Immunotherapy Market Size Share by Regions (2019-2025)
Figure Global Oncolytic Virus Immunotherapy Market Size Share by Regions in 2025
Figure United States Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure China Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure India Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oncolytic Virus Immunotherapy Market Size Forecast (2019-2025)(Million USD)
Table Global Oncolytic Virus Immunotherapy Market Size by Product (2019-2025) (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size by Product (2019-2025)
Figure Global Oncolytic Virus Immunotherapy Market Size by Product in 2025
Table Global Oncolytic Virus Immunotherapy Market Size by Application (2019-2025) (Million US$)
Figure Global Oncolytic Virus Immunotherapy Market Size by Application (2019-2025)
Figure Global Oncolytic Virus Immunotherapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ヒトパラインフルエンザウイルス診断の世界市場：市場規模・現状・予測 Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…- ヒトパラインフルエンザウイルス診断の世界市場：市場規模・現状・予測 Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- おたふく風邪ウイルス検査の世界市場：市場規模・現状・予測 Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…
- C型肝炎ウイルス（HCV）の世界市場：市場規模・現状・予測 Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- 血液ウイルス検査の世界市場：市場規模・現状・予測 Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …